Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
08/09/20229:23AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:INABIN8bio Inc
08/08/20226:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INABIN8bio Inc
08/08/20226:49AMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:INABIN8bio Inc
07/27/20228:35AMTipRanksMizuho Securities Sticks to Their Buy Rating for IN8bio (INAB)NASDAQ:INABIN8bio Inc
07/27/20228:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INABIN8bio Inc
07/27/20227:00AMGlobeNewswire Inc.IN8bio Observes Durable Morphologic Complete Responses in Ongoing Phase 1 Clinical Trial of INB-100, an Allogeneic Gamma-Delta T Cell Therapy in High-Risk Leukemia PatientsNASDAQ:INABIN8bio Inc
07/21/202212:25PMTipRanksMizuho Securities Keeps a Buy Rating on IN8bio (INAB)NASDAQ:INABIN8bio Inc
07/21/20227:00AMGlobeNewswire Inc.Newly Issued European Patent Broadens IN8bio’s Drug Resistant Immunotherapy (DRI) PlatformNASDAQ:INABIN8bio Inc
07/12/20228:00AMGlobeNewswire Inc.IN8bio Appoints Kenneth R. LaMontagne, Ph.D., to Lead Business DevelopmentNASDAQ:INABIN8bio Inc
06/30/20224:15PMGlobeNewswire Inc.IN8bio to Present at July Investor and Scientific ConferencesNASDAQ:INABIN8bio Inc
06/14/20227:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
06/14/20227:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
06/14/20227:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
06/08/20229:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INABIN8bio Inc
06/08/20228:00AMGlobeNewswire Inc.IN8bio Announces Presentation at Jefferies Global Healthcare Conference and Additional June Investor and Scientific ConferencesNASDAQ:INABIN8bio Inc
06/06/20227:00AMGlobeNewswire Inc.IN8bio Announces Positive Glioblastoma Multiforme (GBM) Clinical Updates from the INB-200 Phase 1 Trial Presented at ASCO 2022NASDAQ:INABIN8bio Inc
06/02/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INABIN8bio Inc
05/18/20224:25AMTipRanksIN8bio (INAB) Gets a Buy Rating from Mizuho SecuritiesNASDAQ:INABIN8bio Inc
05/17/20227:00AMGlobeNewswire Inc.IN8bio Announces Data Emerging from its Recently Unveiled Gamma-Delta T cell “Off-the-Shelf” Induced Pluripotent Stem Cell PlatformNASDAQ:INABIN8bio Inc
05/12/20224:14PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INABIN8bio Inc
05/12/20221:25PMTipRanksMizuho Securities Maintains Their Buy Rating on IN8bio (INAB)NASDAQ:INABIN8bio Inc
05/12/20228:20AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INABIN8bio Inc
05/12/20228:00AMGlobeNewswire Inc.IN8bio Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:INABIN8bio Inc
05/09/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
05/05/20228:00AMGlobeNewswire Inc.IN8bio Unveils Induced Pluripotent Stem Cell (iPSC) Platform at ASGCT 25th Annual MeetingNASDAQ:INABIN8bio Inc
05/04/20228:00AMGlobeNewswire Inc.IN8bio to Present at May Investor and Scientific ConferencesNASDAQ:INABIN8bio Inc
05/03/20224:45PMTipRanksMizuho Securities Thinks IN8bio’s Stock is Going to RecoverNASDAQ:INABIN8bio Inc
04/22/20224:07PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INABIN8bio Inc
04/22/20224:01PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INABIN8bio Inc
04/13/20228:30AMGlobeNewswire Inc.IN8bio Continues to Build on its Clinical and Regulatory Team with Two Key AppointmentsNASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB